CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishThe pure antiestrogen ICI 182,780 inhibits insulin-like growth factor (IGF)-dependent proliferation in hormoneresponsive breast cancer cells. However, the interactions of ICI 182,780 with IGF-I receptor (IGF-IR) intracellular signaling have not been characterized. Here, we studied the effects of ICI 182,780 on IGF-IR signal transduction in MCF-7 breast cancer cells and in MCF-7-derived clones overexpressing either the IGF-IR or its 2 major substrates, insulin receptor substrate 1 (IRS-1) or src/collagen homology proteins (SHC). ICI 182,780 blocked the basal and IGF-I-induced growth in all studied cells in a dose-dependent manner; however, the clones with the greatest IRS-1 overexpression were clearly least sensitive to the drug. Pursuing ICI 182,780 interaction with IRS-1, we found that the antiestrogen reduced IRS-1 expression and tyrosine phosphorylation in several cell lines in the presence or absence of IGF-I. Moreover, in IRS-1- overexpressing cells, ICI 182,780 decreased IRS-1/p85 and IRS-1/GRB2 binding. The effects of ICI 182,780 on IGF-IR protein expression were not significant; however, the drug suppressed IGF-I-induced (but not basal) IGF-IR tyrosine phosphorylation. The expression and tyrosine phosphorylation of SHC as well as SHC/GRB binding were not influenced by ICI 182,780. In summary, downregulation of IRS-1 may represent one of the mechanisms by which ICI 182,780 inhibits the growth of breast cancer cells. Thus, overexpression of IRS-1 in breast tumors could contribute to the development of antiestrogen resistance.
Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells / Salerno, M; Sisci, Diego; Mauro, Loredana; Guvakova, Ma; Ando', S; Surmacz, E.. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - 81(1999), pp. 299-304.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
| Titolo: | Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells | |
| Autori: | ||
| Data di pubblicazione: | 1999 | |
| Rivista: | ||
| Citazione: | Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells / Salerno, M; Sisci, Diego; Mauro, Loredana; Guvakova, Ma; Ando', S; Surmacz, E.. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - 81(1999), pp. 299-304. | |
| Handle: | http://hdl.handle.net/20.500.11770/136515 | |
| Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Copyright © 2021